Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.3084
Delayed Data
As of 3:51pm ET
 -0.0016 / -0.52%
Today’s Change
0.19
Today|||52-Week Range
2.51
-33.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues36.3M36.6M3.0M3.6M
 
 
 
 
 
Cost of Goods Sold29.9M29.1M892.0K1.7M
 
 
 
 
 
Depreciation And Amortization1.3M1.3M1.3M1.1M
 
 
 
 
 
 
Operating ExpensesGross Income5.1M6.2M886.0K800.0K
 
 
 
 
 
General Expenses10.9M10.2M4.2M3.7M
 
 
 
 
 
Research And Development414.0K1.0M323.0K357.0K
 
 
 
 
 
Total Operating Expenses42.1M40.6M6.4M6.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.8M-4.0M-3.3M-2.9M
 
 
 
 
 
Extraordinary Charge-116.0K-28.0K-459.0K0.00
 
 
 
 
Interest Expense On Debt884.0K969.0K203.0K858.0K
 
 
 
 
 
Other Expenses-97.0K1.0K6.0K3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.9M-5.0M-4.0M-3.7M
 
 
 
 
 
Income Taxes-177.0K-180.0K-9.0K-236.0K
 
 
 
 
 
Discontinued Operations-264.0K-76.0K-780.0K1.2M
 
 
 
 
 
Net Income-7.0M-4.9M-4.8M-2.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.2M15.7M17.8M18.2M
 
 
 
 
 
Shares To Calculate EPS Diluted15.2M15.7M17.8M18.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.46-$0.31-$0.27-$0.13
 
 
 
 
 
EPS Diluted-$0.46-$0.31-$0.27-$0.13